Attendees will deepen their understanding of the pharmacologic landscape—including the use of erythropoiesis-stimulating agents, intravenous and oral iron, and emerging therapies—and learn how to apply these tools in dialysis, transplant, and conservative care settings. Special emphasis will be placed on managing anemia in unique populations such as those with polycystic kidney disease (PKD), patients receiving renal replacement therapies (RRTs), and individuals post kidney transplantation